Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-23-013286

Options or other derivatives

  • President and CEO acquired 160,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tesi Raymond Joseph · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-16 Grant or award : show line 1 in the form Option (right to buy) +160,000 160,000 D
Loading xslF345X03/ownership.xml…